• 1
    Cornillon J, Bernard JP, Gueho E, Touraine R. Estivo-autumnal pollinosis. Rev Fr Allergol 1972;12: 313322.
  • 2
    Spieksma FT, Charpin H, Nolard N, Stix E. City spore concentrations in the European Economic Community (EEC). IV. Summer weed pollen (Rumex, Plantago, Chenopodiaceae, Artemisia), 1976 and 1977. Clin Allergy 1980;10: 319329.
  • 3
    Himly M, Jahn-Schmid B, Dedic A, Kelemen P, Wopfner N, Altmann F et al. Art v 1, the major allergen of mugwort pollen, is a modular glycoprotein with a defensin-like and a hydroxyproline-rich domain. Faseb J 2003;17: 106108.
  • 4
    Gurunathan S, Klinman DM, Seder RA. DNA vaccines: immunology, application, and optimization. Annu Rev Immunol 2000;18: 927974.
  • 5
    Seder RA, Gurunathan S. DNA vaccines – designer vaccines for the 21st century. N Engl J Med 1999;341: 277278.
  • 6
    Raz E, Tighe H, Sato Y, Corr M, Dudler JA, Roman M et al. Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization. Proc Natl Acad Sci USA 1996;93: 51415145.
  • 7
    Slater JE, Paupore E, Zhang YT, Colberg-Poley AM. The latex allergen Hev b 5 transcript is widely distributed after subcutaneous injection in BALB/c mice of its DNA vaccine. J Allergy Clin Immunol 1998;102: 469475.
  • 8
    Hsu CH, Chua KY, Tao MH, Lai YL, Wu HD, Huang SK et al. Immunoprophylaxis of allergen-induced immunoglobulin E synthesis and airway hyperresponsiveness in vivo by genetic immunization. Nat Med 1996;2: 540544.
  • 9
    Hochreiter R, Hartl A, Freund J, Valenta R, Ferreira F, Thalhamer J. The influence of CpG motifs on a protein or DNA-based Th2-type immune response against major pollen allergens Bet v 1a, Phl p 2 and Escherichia coli-derived beta-galactosidase. Int Arch Allergy Immunol 2001;124: 406410.
  • 10
    Hartl A, Kiesslich J, Weiss R, Bernhaupt A, Mostbock S, Scheiblhofer S et al. Immune responses after immunization with plasmid DNA encoding Bet v 1, the major allergen of birch pollen. J Allergy Clin Immunol 1999;103: 107113.
  • 11
    Hartl A, Kiesslich J, Weiss R, Bernhaupt A, Mostbock S, Scheiblhofer S et al. Isoforms of the major allergen of birch pollen induce different immune responses after genetic immunization. Int Arch Allergy Immunol 1999;120: 1729.
  • 12
    Leitner WW, Hammerl P, Thalhamer J. Nucleic acid for the treatment of cancer: genetic vaccines and DNA adjuvants. Curr Pharm Des 2001;7: 16411667.
  • 13
    Liu WJ, Zhao KN, Gao FG, Leggatt GR, Fernando GJ, Frazer IH. Polynucleotide viral vaccines: codon optimisation and ubiquitin conjugation enhances prophylactic and therapeutic efficacy. Vaccine 2001;20: 862869.
  • 14
    Stratford R, Douce G, Zhang-Barber L, Fairweather N, Eskola J, Dougan G. Influence of codon usage on the immunogenicity of a DNA vaccine against tetanus. Vaccine 2000;19: 810815.
  • 15
    Nagata T, Uchijima M, Yoshida A, Kawashima M, Koide Y. Codon optimization effect on translational efficiency of DNA vaccine in mammalian cells: analysis of plasmid DNA encoding a CTL epitope derived from microorganisms. Biochem Biophys Res Commun 1999;261: 445451.
  • 16
    Andre S, Seed B, Eberle J, Schraut W, Bultmann A, Haas J. Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage. J Virol 1998;72: 14971503.
  • 17
    Leder C, Kleinschmidt JA, Wiethe C, Muller M. Enhancement of capsid gene expression: preparing the human papillomavirus type 16 major structural gene L1 for DNA vaccination purposes. J Virol 2001;75: 92019209.
  • 18
    Peng HJ, Su SN, Chang ZN, Chao PL, Kuo SW, Tsai LC. Induction of specific Th1 responses and suppression of IgE antibody formation by vaccination with plasmid DNA encoding Der f 11. Vaccine 2002;20: 17611768.
  • 19
    Nakamura Y, Gojobori T, Ikemura T. Codon usage tabulated from international DNA sequence databases: status for the year 2000. Nucleic Acids Res 2000;28: 292.
  • 20
    Scheiblhofer S, Chen D, Weiss R, Khan F, Mostbock S, Fegeding K et al. Removal of the circumsporozoite protein (CSP) glycosylphosphatidylinositol signal sequence from a CSP DNA vaccine enhances induction of CSP-specific Th2 type immune responses and improvesprotection against malaria infection. Eur J Immunol 2001;31: 692698.
  • 21
    Roy K, Mao HQ, Huang SK, Leong KW. Oral gene delivery with chitosan – DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat Med 1999;5: 387391.
  • 22
    Weiss R, Durnberger J, Mostbock S, Scheiblhofer S, Hartl A, Breitenbach M et al. Improvement of the immune response against plasmid DNA encoding OspC of Borrelia by an ER-targeting leader sequence. Vaccine 1999;18: 815824.
  • 23
    Xiang Z, Ertl HC. Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines. Immunity 1995;2: 129135.
  • 24
    Gregoriadis G, Saffie R, Souza JB. Liposome-mediated DNA vaccination. Febs Lett 1997;402: 107110.
  • 25
    Grantham R, Gautier C, Gouy M, Jacobzone M, Mercier R. Codon catalog usage is a genome strategy modulated for gene expressivity. Nucleic Acids Res 1981;9: r4374.
  • 26
    Ikemura T. Correlation between the abundance of Escherichia coli transfer RNAs and the occurrence of the respective codons in its protein genes. J Mol Biol 1981;146: 121.
  • 27
    Barry MA, Johnston SA. Biological features of genetic immunization. Vaccine 1997;15: 788791.
  • 28
    Ikemura T. Codon usage and tRNA content in unicellular and multicellular organisms. Mol Biol Evol 1985;2: 1334.
  • 29
    Ikemura T. Correlation between the abundance of yeast transfer RNAs and the occurrence of the respective codons in protein genes. Differences in synonymous codon choice patterns of yeast and Escherichia coli with reference to the abundance of isoaccepting transfer RNAs. J Mol Biol 1982;158: 573597.
  • 30
    Zolotukhin S, Potter M, Hauswirth WW, Guy J, Muzyczka N. A “humanized” green fluorescent protein cDNA adapted for high-level expression in mammalian cells. J Virol 1996;70: 46464654.
  • 31
    Haas J, Park EC, Seed B. Codon usage limitation in the expression of HIV-1 envelope glycoprotein. Curr Biol 1996;6: 315324.
  • 32
    Donnelly JJ, Ulmer JB, Shiver JW, Liu MA. DNA vaccines. Annu Rev Immunol 1997;15: 617648.
  • 33
    Adel-Patient K, Creminon C, Boquet D, Wal JM, Chatel JM. Genetic immunisation with bovine beta-lactoglobulin cDNA induces a preventive and persistent inhibition of specific anti-BLG IgE response in mice. Int Arch Allergy Immunol 2001;126: 5967.